LY3039478

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LY3039478, covering 2019-02-06 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3039478 in Participants With Advanced Cancer [Phase 1]